238 related articles for article (PubMed ID: 33383743)
1. ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood-Brain Barrier.
Topal GR; Mészáros M; Porkoláb G; Szecskó A; Polgár TF; Siklós L; Deli MA; Veszelka S; Bozkir A
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33383743
[TBL] [Abstract][Full Text] [Related]
2. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
[TBL] [Abstract][Full Text] [Related]
3. A Triple Combination of Targeting Ligands Increases the Penetration of Nanoparticles across a Blood-Brain Barrier Culture Model.
Veszelka S; Mészáros M; Porkoláb G; Szecskó A; Kondor N; Ferenc G; Polgár TF; Katona G; Kóta Z; Kelemen L; Páli T; Vigh JP; Walter FR; Bolognin S; Schwamborn JC; Jan JS; Deli MA
Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056983
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
[TBL] [Abstract][Full Text] [Related]
5. Donepezil-Loaded Nanocarriers for the Treatment of Alzheimer's Disease: Superior Efficacy of Extracellular Vesicles Over Polymeric Nanoparticles.
Oliveira Silva R; Counil H; Rabanel JM; Haddad M; Zaouter C; Ben Khedher MR; Patten SA; Ramassamy C
Int J Nanomedicine; 2024; 19():1077-1096. PubMed ID: 38317848
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of rosmarinic acid across the blood-brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide-co-glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E.
Kuo YC; Rajesh R
Int J Pharm; 2017 Aug; 528(1-2):228-241. PubMed ID: 28549973
[TBL] [Abstract][Full Text] [Related]
7. Lecithin coating as universal stabilization and functionalization strategy for nanosized drug carriers to overcome the blood-brain barrier.
Wünsch A; Mulac D; Langer K
Int J Pharm; 2021 Jan; 593():120146. PubMed ID: 33279714
[TBL] [Abstract][Full Text] [Related]
8. A combination of receptor mediated transcytosis and photothermal effect promotes BBB permeability and the treatment of meningitis using itraconazole.
Zhang SS; Asghar S; Ye JX; Lin L; Ping QN; Chen ZP; Shao F; Xiao YY
Nanoscale; 2020 Dec; 12(46):23709-23720. PubMed ID: 33231242
[TBL] [Abstract][Full Text] [Related]
9. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
10. From adsorption to covalent bonding: Apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Hartl N; Adams F; Merkel OM
Adv Ther (Weinh); 2021 Jan; 4(1):. PubMed ID: 33542947
[TBL] [Abstract][Full Text] [Related]
11. Design and development of donepezil hydrochloride loaded nanostructured lipid carriers for efficient management of Alzheimer's disease.
Tekade AR; Suryavanshi MR; Shewale AB; Patil VS
Drug Dev Ind Pharm; 2023 Sep; 49(9):590-600. PubMed ID: 37733474
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein imitating nanoparticles: Lecithin coating binds ApoE and mediates non-lysosomal uptake leading to transcytosis over the blood-brain barrier.
Wünsch A; Mulac D; Langer K
Int J Pharm; 2020 Nov; 589():119821. PubMed ID: 32861770
[TBL] [Abstract][Full Text] [Related]
13. Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo.
Zhang ZA; Xin X; Liu C; Liu YH; Duan HX; Qi LL; Zhang YY; Zhao HM; Chen LQ; Jin MJ; Gao ZG; Huang W
J Nanobiotechnology; 2021 Dec; 19(1):453. PubMed ID: 34963449
[TBL] [Abstract][Full Text] [Related]
14. ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier.
Dal Magro R; Ornaghi F; Cambianica I; Beretta S; Re F; Musicanti C; Rigolio R; Donzelli E; Canta A; Ballarini E; Cavaletti G; Gasco P; Sancini G
J Control Release; 2017 Mar; 249():103-110. PubMed ID: 28153761
[TBL] [Abstract][Full Text] [Related]
15. Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro.
Baysal I; Ucar G; Gultekinoglu M; Ulubayram K; Yabanoglu-Ciftci S
J Neural Transm (Vienna); 2017 Jan; 124(1):33-45. PubMed ID: 26911385
[TBL] [Abstract][Full Text] [Related]
16. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.
Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
Int J Nanomedicine; 2019; 14():6497-6517. PubMed ID: 31616141
[TBL] [Abstract][Full Text] [Related]
17. Nanobiotechnology-based drug delivery in brain targeting.
Dinda SC; Pattnaik G
Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
[TBL] [Abstract][Full Text] [Related]
18. Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood-Brain Barrier Transmitters.
Amiri M; Jafari S; Kurd M; Mohamadpour H; Khayati M; Ghobadinezhad F; Tavallaei O; Derakhshankhah H; Sadegh Malvajerd S; Izadi Z
ACS Chem Neurosci; 2021 Dec; 12(24):4475-4490. PubMed ID: 34841846
[TBL] [Abstract][Full Text] [Related]
19. Biotin and Glutathione Targeting of Solid Nanoparticles to Cross Human Brain Endothelial Cells.
Veszelka S; Meszaros M; Kiss L; Kota Z; Pali T; Hoyk Z; Bozso Z; Fulop L; Toth A; Rakhely G; Deli MA
Curr Pharm Des; 2017; 23(28):4198-4205. PubMed ID: 28748755
[TBL] [Abstract][Full Text] [Related]
20. Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Colloids Surf B Biointerfaces; 2023 Jan; 221():112999. PubMed ID: 36368148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]